Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2019 16:30 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. to Present at 2019 Cantor Global Healthcare Conference

WIXOM, Mich., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled...
September 05, 2019 16:30 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. Appoints Industry Veteran John P. McLaughlin to Board of Directors

WIXOM, Mich., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients...
August 28, 2019 16:30 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. to Present at Upcoming September Conferences

WIXOM, Mich., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to...
August 08, 2019 16:05 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. Reports Second Quarter 2019 Financial Results

– Company Records First Commercial Sales of Dialysate Triferic®; FDA Accepts New Drug Application for I.V. Triferic with PDUFA date of March 28, 2020 – WIXOM, Mich., Aug. 08, 2019 (GLOBE...
August 08, 2019 06:50 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. Announces Completion of Two Clinical Pharmacology Studies of TRIFERIC® in China

– Positive data suggests no ethnic difference in Triferic PK in Chinese subjects compared to U.S. subjects – – China studies indicate similar delivery of iron via dialysate as in U.S. studies – ...
August 06, 2019 06:50 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. Announces Acceptance by FDA of New Drug Application for I.V. TRIFERIC®

WIXOM, Mich., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients...
July 29, 2019 16:30 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. to Discuss Second Quarter 2019 Financial Results on August 8, 2019

WIXOM, Mich., July 29, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2019 second quarter...
June 18, 2019 08:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Pricing of $17.5 Million Public Offering of Common Stock

WIXOM, Mich., June 18, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to improving outcomes for patients...
June 17, 2019 16:01 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Proposed Public Offering of Common Stock

WIXOM, Mich., June 17, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to improving outcomes for patients...
June 07, 2019 06:50 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Adjournment of Annual Meeting of Shareholders

- Adjournment solely to vote on Delaware reincorporation Proposal 3(a) - - Both leading independent advisory firms have issued favorable recommendations on proposal - WIXOM, Mich., June 07, 2019 ...